Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Carvedilol for Hypoglycemia Awareness in T1DM
NCT03538015Phase 2Terminated
- Start
- Apr 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in Hypoglycemia unawareness (HU). Started Apr 2019; status: terminated.
02
Drugs
carvedilol
03
Conditions
Hypoglycemia unawareness (HU)
Beyond the preview
Go deeper on NCT03538015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538015.